Cancer therapy and cardiovascular risk: focus on bevacizumab

Overview of attention for article published in Cancer Management and Research, June 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,029 followers.

Cancer therapy and cardiovascular risk: focus on bevacizumab | CMAR https://t.co/GHR8l9lV4g